Diagnosing Anxiety and Depression in the Primary Care Setting

Video

Heidi Combs, MD, says that many patients present to the primary care office thinking that they have other health problems when the diagnosis is really anxiety or depression. She discussed the topic at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California.

Anxiety and depression are quite common, and primary care physicians are often the first to evaluate patients’ symptoms. However, Heidi Combs, MD, associate professor of psychiatry at the University of Washington, says that many patients present to the office thinking they have other health problems.

Combs gave a talk on this topic at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. She explained to MD Magazine that many people don’t have access to a psychiatrist and feel comfortable with the primary care doctor they’ve built trust with.

When a patient comes in complaining of not being able to sleep, pain, or gastrointestinal issues, he or she could actually be experiencing depression or anxiety. “But they don’t realize that what they’re experiencing is depression or anxiety,” Combs explained, “what they experience are these somatic manifestations of their psychic distress.”

There are various effective screening tools for anxiety and depression, such as the GAD-2 or GAD-7. But Combs explained that sometimes the best thing to do is just ask them. “I have 5 screening questions that I ask that screen for the major anxiety disorders for patients,” she said. Watch the video above to hear those 5 questions and more on diagnosing anxiety and depression in the primary care setting.

>>> More Coverage from ACP 2017

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.